Ginkgo Bioworks Holdings (DNABW) Accumulated Depreciation (2020 - 2023)

Ginkgo Bioworks Holdings has reported Accumulated Depreciation for 4 years, with the latest figure at $118.5 million in Q2 2023.

• For the quarter ending Q2 2023, Accumulated Depreciation rose 51.47% year-over-year to $118.5 million; the trailing twelve-month figure through Jun 2023 stood at $118.5 million (up 51.47% YoY), and the FY2022 full-year result was $92.8 million, up 51.93% from the prior year.
• Accumulated Depreciation for Q2 2023 stood at $118.5 million, up from $107.3 million in the prior quarter.
• The five-year high for Accumulated Depreciation was $118.5 million in Q2 2023, with the low at $33.8 million in Q4 2020.
• Historically, Accumulated Depreciation has averaged $77.6 million across 4 years, with a median of $78.2 million in 2022.
• Annual changes were most pronounced in 2021 — Accumulated Depreciation jumped 80.74% — and 2023, when it soared 51.47%.
• Ginkgo Bioworks Holdings' Accumulated Depreciation stood at $33.8 million in 2020, then soared by 80.74% to $61.1 million in 2021, then soared by 51.93% to $92.8 million in 2022, then rose by 27.72% to $118.5 million in 2023.
• The last three Accumulated Depreciation figures came in at $118.5 million (Q2 2023), $107.3 million (Q1 2023), and $92.8 million (Q4 2022), per Business Quant data.